LabReport (#671)

Name
Modus Presidential Gummies Lab Report 1
Sample Name
MODUS Presidential Gummies - Watermelon Breeze
Sample Matrix
gummies
Product Type
cannabis
Lab Name
PharmLabs San Diego
Matching Name
Modus Presidential Gummies Lab Report 1 MODUS Presidential Gummies - Watermelon Breeze gummies
Category
Null
Type
jpg
State
Processed
Additional Data

Extraction Date: 2023-02-27

Expiry Date:

Delta-9 %: 0.24

THC-A %: 0

Total THC %: 0.24

D9/THC-A %: 0.24

Debug Data
Null
Markdown Content
"# SD250217-030 page 1 of 2\n\n## PharmLabs San Diego Certificate of Analysis\n\n**Sample:** MODUS Presidential Gummies - Watermelon Breeze \n**Delta9 THC:** 0.24% \n**THCa:** ND \n**Total THC (THCa * 0.877 + THC):** 0.24% \n**Delta8 THC:** 3.18%\n\n### Sample Information\n\n- **Sample ID:** SD250217-030 (R&D)\n- **Tested for:** California Dispensary Distribution\n- **Received:** Feb 27, 2023\n- **Reported:** Feb 28, 2023\n- **Analyst:** A. Clark, PhD\n- **Lot Number:** 0323W\n- **Serving Size:** 4.5g\n- **Serving Size (mg):** 4500mg\n- **Number of Servings:** 20\n\n----\n\n## CAN - Cannabinoids\n\n**Analyzed on:** Feb 28, 2023 | Instrument: HPLC-VWD | Method: SOP-001\n\n### Summary of Results\n\nThe following is a summary of the Cannabinoids analyzed in the sample at the 95% Confidence Level.\n\n| Analyte | LOQ | LOD | Result | Result (mg\/g) | Result (%) | Sample Photography |\n|-------------------------------|------|------|--------|---------------|------------|--------------------|\n| Cannabidivarin (CBDV) | 0.01 | 0.01 | ND | ND | ND | !Sample Image |\n| Cannabidivarinic Acid (CBDVA) | 0.01 | 0.01 | ND | ND | ND | |\n| Cannabigerol (CBG) | 0.01 | 0.01 | ND | ND | ND | |\n| Cannabigerolic Acid (CBGA) | 0.01 | 0.01 | ND | ND | ND | |\n| Cannabidiol (CBD) | 0.01 | 0.01 | ND | ND | ND | |\n| Cannabidiolic Acid (CBDA) | 0.01 | 0.01 | ND | ND | ND | |\n| Tetrahydrocannabivarin (THCV) | 0.01 | 0.01 | ND | ND | ND | |\n| Tetrahydrocannabivarinic Acid (THCVA) | 0.01 | 0.01 | ND | ND | ND | |\n| Delta9-Tetrahydrocannabinol (THC) | 0.01 | 0.01 | 0.011 | 0.24 | 0.24 | |\n| Delta9-Tetrahydrocannabinolic Acid (THCA) | 0.01 | 0.01 | ND | ND | ND | |\n| Delta8-Tetrahydrocannabinol (D8THC) | 0.01 | 0.01 | 0.144 | 3.18 | 3.18 | |\n| Cannabinol (CBN) | 0.01 | 0.01 | ND | ND | ND | |\n| Cannabichromene (CBC) | 0.01 | 0.01 | ND | ND | ND | |\n| Cannabicyclol (CBL) | 0.01 | 0.01 | ND | ND | ND | |\n| Total THC (THCA * 0.877 + THC) | 0.01 | 0.01 | 0.011 | 0.24 | 0.24 | |\n| Total CBD (CBDA * 0.877 + CBD) | 0.01 | 0.01 | ND | ND | ND | |\n| Total Cannabinoids | 0.01 | 0.01 | 0.155 | 3.42 | 3.42 | |\n\n----\n\n## HME - Heavy Metals\n\n**Analyzed on:** Feb 28, 2023 | Instrument: ICP-MS\/ICP-OES | Method: SOP-005\n\n| Analyte | LOQ | LOD | Result | Result (mg\/g) | Limit (mg\/g) |\n|---------|-------|-------|--------|---------------|--------------|\n| Arsenic (As) | 0.0015 | 0.0010 | 0.0011 | 0.0002 | 0.2 |\n| Cadmium (Cd) | 0.0005 | 0.0003 | 0.0002 | 0.0000 | 0.2 |\n| Mercury (Hg) | 0.0010 | 0.0005 | 0.0003 | 0.0001 | 0.1 |\n| Lead (Pb) | 0.0010 | 0.0005 | 0.0005 | 0.0001 | 0.5 |\n\n----\n\n## MIBIG - Microbial\n\n**Analyzed on:** Feb 28, 2023 | Instrument: qPCR and\/or Plating | Method: SOP-007\n\n| Analyte | LOQ | LOD | Result | Limit |\n|---------|-----|-----|--------|-------|\n| Bile-tolerant gram-negative bacteria (CFU) | 10 | 10 | ND | 1 |\n| Shiga toxin-producing Escherichia Coli | 1 | 1 | ND | 1 |\n| Salmonella species | 1 | 1 | ND | 1 |\n| Total Coliforms | 10 | 10 | ND | 1 |\n| Aspergillus flavus | 1 | 1 | ND | 1 |\n| Aspergillus fumigatus | 1 | 1 | ND | 1 |\n| Aspergillus niger | 1 | 1 | ND | 1 |\n| Aspergillus terreus | 1 | 1 | ND | 1 |\n\n----\n\n## MTO - Mycotoxin\n\n**Analyzed on:** Feb 28, 2023 | Instrument: LC-MS\/MS | Method: SOP-006\n\n| Analyte | LOQ | LOD | Result | Limit |\n|---------|-----|-----|--------|-------|\n| Aflatoxin B1 | 2.5 | 5.0 | ND | 20 |\n| Aflatoxin B2 | 2.5 | 5.0 | ND | 20 |\n| Aflatoxin G1 | 2.5 | 5.0 | ND | 20 |\n| Aflatoxin G2 | 2.5 | 5.0 | ND | 20 |\n| Total Aflatoxins | 5.0 | 10.0 | ND | 20 |\n\n----\n\n**Authorized Signature:** \nBrandon Stark\n\n**License:** C8-0000066-LIC \n**Accreditation:** ISO\/IEC 17025:2017\n\n**Contact Information:** \nPharmLabs San Diego \n4918 N. Harbor Dr., Suite 204, San Diego, CA 92106 \nPhone: (619) 356-0898 \nEmail: info@pharmlabs.com"